These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

441 related items for PubMed ID: 28934744

  • 1. Association of Serum Amyloid A with Kidney Outcomes and All-Cause Mortality in American Indians with Type 2 Diabetes.
    Saulnier PJ, Dieter BP, Tanamas SK, McPherson SM, Wheelock KM, Knowler WC, Looker HC, Meek RL, Nelson RG, Tuttle KR.
    Am J Nephrol; 2017; 46(4):276-284. PubMed ID: 28934744
    [Abstract] [Full Text] [Related]

  • 2. Filtration markers as predictors of ESRD and mortality in Southwestern American Indians with type 2 diabetes.
    Foster MC, Inker LA, Hsu CY, Eckfeldt JH, Levey AS, Pavkov ME, Myers BD, Bennett PH, Kimmel PL, Vasan RS, Coresh J, Nelson RG, CKD Biomarkers Consortium.
    Am J Kidney Dis; 2015 Jul; 66(1):75-83. PubMed ID: 25773485
    [Abstract] [Full Text] [Related]

  • 3. Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease.
    Dieter BP, McPherson SM, Afkarian M, de Boer IH, Mehrotra R, Short R, Barbosa-Leiker C, Alicic RZ, Meek RL, Tuttle KR.
    J Diabetes Complications; 2016 Jul; 30(8):1467-1472. PubMed ID: 27522272
    [Abstract] [Full Text] [Related]

  • 4. Albuminuria and estimated glomerular filtration rate as predictors of diabetic end-stage renal disease and death.
    Berhane AM, Weil EJ, Knowler WC, Nelson RG, Hanson RL.
    Clin J Am Soc Nephrol; 2011 Oct; 6(10):2444-51. PubMed ID: 21852671
    [Abstract] [Full Text] [Related]

  • 5. Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus.
    Fufaa GD, Weil EJ, Nelson RG, Hanson RL, Bonventre JV, Sabbisetti V, Waikar SS, Mifflin TE, Zhang X, Xie D, Hsu CY, Feldman HI, Coresh J, Vasan RS, Kimmel PL, Liu KD, Chronic Kidney Disease Biomarkers Consortium Investigators.
    Diabetologia; 2015 Jan; 58(1):188-98. PubMed ID: 25316431
    [Abstract] [Full Text] [Related]

  • 6. Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes.
    Afkarian M, Zelnick LR, Ruzinski J, Kestenbaum B, Himmelfarb J, de Boer IH, Mehrotra R.
    J Diabetes Complications; 2015 Jan; 29(8):1024-31. PubMed ID: 26412030
    [Abstract] [Full Text] [Related]

  • 7. Comparison of serum cystatin C, serum creatinine, measured GFR, and estimated GFR to assess the risk of kidney failure in American Indians with diabetic nephropathy.
    Pavkov ME, Knowler WC, Hanson RL, Williams DE, Lemley KV, Myers BD, Nelson RG.
    Am J Kidney Dis; 2013 Jul; 62(1):33-41. PubMed ID: 23347458
    [Abstract] [Full Text] [Related]

  • 8. Structural Predictors of Loss of Renal Function in American Indians with Type 2 Diabetes.
    Fufaa GD, Weil EJ, Lemley KV, Knowler WC, Brosius FC, Yee B, Mauer M, Nelson RG.
    Clin J Am Soc Nephrol; 2016 Feb 05; 11(2):254-61. PubMed ID: 26792530
    [Abstract] [Full Text] [Related]

  • 9. Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy.
    Galsgaard J, Persson F, Hansen TW, Jorsal A, Tarnow L, Parving HH, Rossing P.
    Kidney Int; 2017 Nov 05; 92(5):1242-1248. PubMed ID: 28712855
    [Abstract] [Full Text] [Related]

  • 10. Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis.
    Kopecky C, Genser B, Drechsler C, Krane V, Kaltenecker CC, Hengstschläger M, März W, Wanner C, Säemann MD, Weichhart T.
    Clin J Am Soc Nephrol; 2015 Feb 06; 10(2):224-31. PubMed ID: 25424990
    [Abstract] [Full Text] [Related]

  • 11. Urine Complement Proteins and the Risk of Kidney Disease Progression and Mortality in Type 2 Diabetes.
    Vaisar T, Durbin-Johnson B, Whitlock K, Babenko I, Mehrotra R, Rocke DM, Afkarian M.
    Diabetes Care; 2018 Nov 06; 41(11):2361-2369. PubMed ID: 30150236
    [Abstract] [Full Text] [Related]

  • 12. Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes.
    Pavkov ME, Nelson RG, Knowler WC, Cheng Y, Krolewski AS, Niewczas MA.
    Kidney Int; 2015 Apr 06; 87(4):812-9. PubMed ID: 25272234
    [Abstract] [Full Text] [Related]

  • 13. Soluble Urokinase Plasminogen Activator Receptor and Outcomes in Patients with Diabetes on Hemodialysis.
    Drechsler C, Hayek SS, Wei C, Sever S, Genser B, Krane V, Meinitzer A, März W, Wanner C, Reiser J.
    Clin J Am Soc Nephrol; 2017 Aug 07; 12(8):1265-1273. PubMed ID: 28495863
    [Abstract] [Full Text] [Related]

  • 14. Urine IgM-excretion as a prognostic marker for progression of type 2 diabetic nephropathy.
    Tofik R, Torffvit O, Rippe B, Bakoush O.
    Diabetes Res Clin Pract; 2012 Jan 07; 95(1):139-44. PubMed ID: 22078636
    [Abstract] [Full Text] [Related]

  • 15. Association of serum concentration of TNFR1 with all-cause mortality in patients with type 2 diabetes and chronic kidney disease: follow-up of the SURDIAGENE Cohort.
    Saulnier PJ, Gand E, Ragot S, Ducrocq G, Halimi JM, Hulin-Delmotte C, Llaty P, Montaigne D, Rigalleau V, Roussel R, Velho G, Sosner P, Zaoui P, Hadjadj S, SURDIAGENE Study Group.
    Diabetes Care; 2014 May 07; 37(5):1425-31. PubMed ID: 24623026
    [Abstract] [Full Text] [Related]

  • 16. Predictive power of sequential measures of albuminuria for progression to ESRD or death in Pima Indians with type 2 diabetes.
    Pavkov ME, Knowler WC, Hanson RL, Bennett PH, Nelson RG.
    Am J Kidney Dis; 2008 May 07; 51(5):759-66. PubMed ID: 18436086
    [Abstract] [Full Text] [Related]

  • 17. Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians.
    Pavkov ME, Bennett PH, Knowler WC, Krakoff J, Sievers ML, Nelson RG.
    JAMA; 2006 Jul 26; 296(4):421-6. PubMed ID: 16868300
    [Abstract] [Full Text] [Related]

  • 18. 25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.
    Fernández-Juárez G, Luño J, Barrio V, de Vinuesa SG, Praga M, Goicoechea M, Lahera V, Casas L, Oliva J, PRONEDI Study Group.
    Clin J Am Soc Nephrol; 2013 Nov 26; 8(11):1870-6. PubMed ID: 24135218
    [Abstract] [Full Text] [Related]

  • 19. Variations in Risk of End-Stage Renal Disease and Risk of Mortality in an International Study of Patients With Type 1 Diabetes and Advanced Nephropathy.
    Skupien J, Smiles AM, Valo E, Ahluwalia TS, Gyorgy B, Sandholm N, Croall S, Lajer M, McDonnell K, Forsblom C, Harjutsalo V, Marre M, Galecki AT, Tregouet DA, Wu CY, Mychaleckyj JC, Nickerson H, Pragnell M, Rich SS, Pezzolesi MG, Hadjadj S, Rossing P, Groop PH, Krolewski AS.
    Diabetes Care; 2019 Jan 26; 42(1):93-101. PubMed ID: 30455333
    [Abstract] [Full Text] [Related]

  • 20. The synergistic relationship between estimated GFR and microalbuminuria in predicting long-term progression to ESRD or death in patients with diabetes: results from the Kidney Early Evaluation Program (KEEP).
    Amin AP, Whaley-Connell AT, Li S, Chen SC, McCullough PA, Kosiborod MN, KEEP Investigators.
    Am J Kidney Dis; 2013 Apr 26; 61(4 Suppl 2):S12-23. PubMed ID: 23507266
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.